The effect of high dose vitamin D3 on the level of serum alkaline phosphatase, calcium, phosphor and vitamin D3 in children older than 3 years old who were receiving phenobarbital

Journal of Zanjan University of Medical Sciences and Health Services

Volumn 18, Issue 72, 2010, Pages 62-70

  Kazemi, S A N ^a   Bordbar, M ^b   Amirmoghaddami, H R ^c   Mousavinasab, N ^d  

^a ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Imam Hassan Mojtaba Hospital   (Iran)

^c ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ZANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epilepsy; Phenobarbital; Vitamin D3

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; COLECALCIFEROL; PHENOBARBITAL; PHOSPHORUS;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MINERAL METABOLISM; PHOSPHATE BLOOD LEVEL; PRESCRIPTION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 77956410054     PISSN: 16069366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wallace SJ, Epilepsy in children. London: chapman & hall Medical; 1996.
2. Valimaki MJ, Tiihonrn M, Laitinen K, et al. Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and desorption in patient on antiepileptic drugs. J Bone Miner Res. 1994; 9: 631-7. (Pubitemid 24130463)
3. Sato Y, Kondo I, Ishida S, et al. Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology. 2001; 57: 445-9.
4. Farhat G, Yamout B, Mikati MA, Dermirjian S, Sawaya R, El-ltajj, Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neorology. 2002; 58: 1348-53. (Pubitemid 34507160)
5. Ecevit C, Aydogan A, Kavakli T, Altinoz S. Effect of carbamazepine and valproate on bone mineral density. Pediatr neurol. 2004; 31: 279-82.
6. Stephen LJ, McLellan AR, Harrison JH. Bone density and antiepileptic drugs: a case controlled study. Seizure. 1999; 8: 339-42.
7. Kafali G, Erselcan T, Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr. 1999; 38: 93-8. (Pubitemid 29086791)
8. Filardis S, Guerreiro CAM, Magna LA, Marques Neto JF. Bone mineral density, vitamin D and anticonvulsant therapy. Arg neuropsiquiatr. 2000; 58: 616-20.
9. Verrotti A, Greco R, Latini G, Morgese G, chiarelli F. Increased bone turnover in prepubertal, pubertal, and post pubertal patients receiving carbamazepine. Epilepsia. 2002; 43: 1488-92.
10. Davie MW, Embereson CE, Lawson DE, et al. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors , consequences and response to treatment with vitamin D. Q J Med. 1983; 52: 79-91.
11. Pack AM , Morrell MJ .Epilepsy and bone health in adults . Epilepsy and behavior .2004; 5: S24-S29.
12. Ashrefi MR, Dehdar F, Rabbani A, et al. Antiepileptic drugs effects on bone metabolism. Iran J Pediatr. 2005; 54: 347-52.
13. Shiva S, Barzegar M. Antiepileptic drugs effects on vitamin D status in epileptic children. Iran J Pediatr. 2008: 60: 167-72.
14. Collins N, Maher J, Cole M, Baker M, Callaghan N. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphates in patients at risk of developing antiepileptic drug- induced osteomalacia. Q J Med. 1991; 78: 113-22.
15. Haan TJ, Halstead LR. Anticonvulsant drug-induced osteomalacia: alterations in mineral metabolism and response to vitamin D3 administration. Calcif Tissue Int. 1979; 27: 13-8.
16. Tjellesen, Gotfredsen A, Christiansen C. Effect of vitamin D2 and D3 on bone- mineral content in carbamazepine-treated epileptic patient. Acta neurol scand. 1983; 68: 424-8.
17. Hoikka V, Savolainen K, Karjalaninen P, Alhava EM, Sivenius J. Treatment of osteomalacia in institutionalized epileptic patients on long - term anticonvulsant therapy. Ann Clin Res. 1982; 14: 72-5 (Pubitemid 12074813)
18. Pedera JD, Canal ML, Carvajal J, et al. Influence of vitamin D administration on bone ultrasound measurements in patients on anticonvulsant therapy. Eur J Clin Invest. 2000; 30: 895-9.
19. kazemi A, Sharifi F, Jafari N, Mousavinasab N. High prevalence of vitamin D deficiency among pregnant women and their newborns in an Iranian population. J Womens Health (Larchmt). 2009; 18: 835-9.